NCT00539968 A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) Status TERMINATED Phase PHASE1/PHASE2
NCT00537121 Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer Status COMPLETED Phase PHASE1
NCT00533533 A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00529412 Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction Status COMPLETED Phase PHASE3
NCT00525785 Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) Status COMPLETED Phase PHASE2
NCT00524186 Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer Status TERMINATED Phase PHASE1
NCT00515411 Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00514020 Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT00512304 Adjuvant Treatment of Gastric Cancer With Chemotherapy and Chemoradiotherapy (TRACE) Status COMPLETED Phase PHASE2
NCT00511576 Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors Status TERMINATED Phase PHASE1
NCT00511264 Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract Status COMPLETED Phase N/A
NCT00503321 Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma Status TERMINATED Phase PHASE2/PHASE3
NCT00502502 Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients Status COMPLETED Phase N/A
NCT00489515 Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder Status COMPLETED Phase N/A
NCT00486356 Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT00477880 Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer Status COMPLETED Phase PHASE1
NCT00477711 A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT00464893 Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection Status COMPLETED Phase PHASE2
NCT00454636 A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. Status COMPLETED Phase PHASE2